BMY DMA



As of date:11/1/2024
BMY stock price:54.32
BMY 50 DMA:50.88
BMY 200 DMA:46.91
BMY MACD (200-50):-3.97

Also see:
BMY Market Cap History
BMY Shares Outstanding History
BMY YTD Return
BMY RSI
BMY MACD
BMY Technical Analysis

Shares of EWZ Now Oversold
Friday, November 1, 9:39 PM


EDV Crowded With Sellers
Friday, November 1, 9:38 PM


Notable Two Hundred Day Moving Average Cross - IUSB
Friday, November 1, 9:38 PM


Notable Two Hundred Day Moving Average Cross - SAR
Friday, November 1, 9:38 PM


Notable Two Hundred Day Moving Average Cross - SUSC
Friday, November 1, 9:38 PM


iShares Broad USD Investment Grade Corporate Bond Breaks Below 200-Day Moving Average - Notable for USIG
Friday, November 1, 9:38 PM


SYLD Crosses Below Key Moving Average Level
Friday, November 1, 9:38 PM


Vanguard Intermediate-Term Corporate Bond (VCIT) Shares Cross Below 200 DMA
Friday, November 1, 9:38 PM


BBDC Crosses Below Key Moving Average Level
Friday, November 1, 9:38 PM


iShares MSCI Indonesia Getting Very Oversold
Friday, November 1, 9:38 PM


UTWO Makes Notable Cross Below Critical Moving Average
Friday, November 1, 9:36 PM


iShares iBonds Dec 2028 Term Treasury (IBTI) Shares Cross Below 200 DMA
Friday, November 1, 9:36 PM


Vanguard Total Corporate Bond Breaks Below 200-Day Moving Average - Notable for VTC
Friday, November 1, 9:36 PM


Notable Two Hundred Day Moving Average Cross - UBND
Friday, November 1, 9:36 PM


ZUMZ Makes Notable Cross Below Critical Moving Average
Friday, November 1, 9:32 PM


More Technical Analysis News

BMY DMABMY MACD
Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s pharmaceutical products include chemically-synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor T-cell therapies. Co.'s primary product includes Eliquis® - Eliquis (apixaban), which is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.

When researching a stock like Bristol-Myers Squibb, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from BMY Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for BMY stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the BMY 200 day moving average ("BMY 200 DMA"), while one of the most popular "shorter look-backs" is the BMY 50 day moving average ("BMY 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Bristol-Myers Squibb.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes

Email EnvelopeFree BMY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Bristol-Myers Squibb (BMY) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

BSX DMA
CAH DMA
CI DMA
CNC DMA
COO DMA
COR DMA
CRL DMA
CTLT DMA
CVS DMA
DGX DMA
More Healthcare companies »

 

BMY DMA | www.StockDMA.com | Copyright © 2019 - 2024, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.